Ms Chu Swee Yeok is the Chief Executive Officer and President of EDBI Pte Ltd where she oversees and leads EDBI’s global direct investments in early to high growth sectors, late-stage companies, and fund investments. With over 30 years of experience, she is responsible for developing and driving the execution of strategies for EDBI, balancing its unique strategic and financial mandates to support new economy sectors such as info-communication, healthcare, emerging technologies, as well as potential local champions in key manufacturing and services related industries.
Prior to EDBI, Ms Chu was the founding CEO of a $1B global investment fund dedicated to catalysing a range of biomedical activities in Singapore, riding on the success of earlier investment funds by the Economic Development Board (EDB) where she built the pioneering fund management teams and oversaw their investment activities. Before her investing career, Ms Chu helmed senior positions at the EDB and the Agency for Science, Technology & Research (A*STAR) where she was instrumental in helping to create a new economic pillar for Singapore, laying the foundation for developing public and private sector talents, and shaping effective business strategies and driving their successful execution.
Besides the EDBI Board and its Executive Committee, she serves on the Board of National Healthcare Group, Singapore-Suzhou Township Development Pte Ltd, Biomedical Sciences Investment Fund Pte Ltd, and a publicly listed company. Additionally, she is a Limited Partner Advisory Committee member of several global private equity / venture capital funds.